| Consolidated Statement of profit and loss |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Amounts in NOK 1 000 |
Note |
2015 |
Revised 2014 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Sales revenue |
8 |
4 608 667 |
4 099 543 |
|
|
|
|
|
|
|
| Other income |
8 |
44 921 |
2 819 |
|
|
|
|
|
|
|
| Other gains and losses |
7 , 8 |
-15 218 |
59 122 |
|
|
|
|
|
|
|
| Share of profit from associated companies |
7 |
6 994 |
3 576 |
|
|
|
|
|
|
|
| Cost of sales |
9 |
-2 738 926 |
-2 293 279 |
|
|
|
|
|
|
|
| Salaries and personnel expenses |
16 / 17 |
-409 432 |
-359 529 |
|
|
|
|
|
|
|
| Other operating expenses |
13 / 17 / 22 / 26 |
-1 235 695 |
-1 028 434 |
|
|
|
|
|
|
|
| Operating profit/loss before depreciation and fair value adjustments of biological assets |
|
261 311 |
483 820 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Depreciation property, plant and equipment |
11 |
-162 211 |
-135 495 |
|
|
|
|
|
|
|
| Depreciation licenses and other intangible assets |
10 |
-5 163 |
-5 222 |
|
|
|
|
|
|
|
| Depreciation property, plant and equipment, and intangible assets |
10 / 11 |
-46 195 |
0 |
|
|
|
|
|
|
|
| Operating profit/loss before fair value adjustment of biological assets |
|
47 742 |
343 104 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Fair value adjustment of biological assets |
9 |
33 209 |
-123 737 |
|
|
|
|
|
|
|
| Operating result |
|
80 951 |
219 366 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share of profit/loss from associated companies |
7 |
3 142 |
2 865 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Financial income |
25 |
38 056 |
57 245 |
|
|
|
|
|
|
|
| Financial expenses |
25 |
-131 357 |
-107 521 |
|
|
|
|
|
|
|
| Net financial loss |
|
-93 301 |
-50 276 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Profit before income tax |
|
-9 208 |
171 956 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Income tax expense |
15 |
13 574 |
-27 561 |
|
|
|
|
|
|
|
| Profit for the year |
|
4 366 |
144 395 |
|
|
|
|
|
|
|
| Allocated to: |
|
|
|
|
|
|
|
|
|
|
| Controlling interests |
|
-6 626 |
138 806 |
|
|
|
|
|
|
|
| Non-controlling interests |
|
10 992 |
5 588 |
|
|
|
|
|
|
|
|
|
|
144 394 |
|
|
|
|
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Resultat tilgjengelig for aksjonærene i morselskapet |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Earnings per share (NOK) |
20 |
-0,06 |
1,26 |
|
|
|
|
|
|
|
| Diluted earnings per share (NOK) |
20 |
-0,06 |
1,26 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Consolidated Comprehensive Income Statement |
|
|
|
|
|
|
|
|
|
| Amounts in NOK 1000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Profit for the year |
|
4 366 |
144 394 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Items with no tax effect on realisation subsequently reversed in profit: |
|
|
|
|
|
|
|
|
|
|
| Currency translation differences, subsidiaries |
|
6 266 |
37 099 |
|
|
|
|
|
|
|
| Change in value of available-for-sale assets |
|
31 |
26 |
|
|
|
|
|
|
|
| Total |
|
6 297 |
37 125 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Items with tax effect on realisation subsequently reversed in profit: |
|
|
|
|
|
|
|
|
|
|
| Currency effect of net investments |
3 |
54 134 |
78 912 |
|
|
|
|
|
|
|
| Tax effect |
|
-13 533 |
-21 306 |
|
|
|
|
|
|
|
| Net effect |
|
40 601 |
57 606 |
|
|
|
|
|
|
|
| Comprehensive income after taxes |
|
46 898 |
94 731 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Total comprehensive income for the year |
|
51 264 |
239 125 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Allocated to: |
|
|
|
|
|
|
|
|
|
|
| Controlling interests |
|
40 272 |
233 537 |
|
|
|
|
|
|
|
| Non-controlling interests |
|
10 992 |
5 588 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Totalresultat tilordnet aksjonærene i morselskapet |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
